MaherJ.F.Physiology of the peritoneum; implications for peritoneal dialysis.Med Clin North Am1990; 74: 985–96.
2.
ShostakA., HirszelP., ChakrabartiE., MaherJ.F.Dihydroergotamine lowers peritoneal transfer rates; a hypovolemic transport decrease. In: AvramM.M., GiordanoC., eds. Ambulatory peritoneal dialysis.New York: Plenum Med, 1990: 79–82.
3.
MaherJ.F., BennettR.R., HirszelP., ChakrabartiE.The mechanism of dextrose-enhanced peritoneal transport rates.Kidney Int1985; 28: 16–20.
4.
PietrzakI., HirszelP., ShostakA., WelchP.G., LeeR.E., MaherJ.F.Splanchnic volume, not flow rate, determines peritoneal penneability.Trans Am Soc Artif Intern Organs1989; 35: 583–7.
5.
RubinJ., JonesQ., PlanchA., StanekK.System of membranes involved in peritoneal dialysis.J Lab Clin Med1987; 110: 448–53.
6.
MaherJ.F., PietrzakI., HirszelP.Role of anions in restricting peritoneal transfer rates.Arq Med1989; 2: 347–9.
7.
GotloibL., Bar SellaP., JaichenkoJ., ShustackA.Ruthenium-red-stained polyanionic fixed charges in peritoneal microvessels.Nephron1987; 47: 22–8.
8.
KredietR.T., KoomenG.C.M., KoopmanM.G.The peritoneal transport of serum proteins and neutral dextran in CAPD patients.Kidney Int1989; 35: 1064–72.
9.
HirszelP., ChakrabartiE., MaherJ.F.Exaggerated protein loss of complicating sterile peritonitis results from increased diffusion.Perit Dial Bull1986; 6: 141–3.
10.
ShostakA., ChakrabartiE., HirszelP., MaherJ.F.Effect of histamine and its receptor antagonists on peritoneal penneability.Kidney Int1988; 34: 786–90.
11.
SteinhauerH.B., SchollmeyerP.Prostaglandin mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis.Kidney Int1986; 29: 584–90.
12.
MaherJ.F., HirszelP., LasrichM.The effect of gastrointestinal honnones on transport by peritoneal dialysis.Kidney Int1979; 16: 130–6.
13.
HirszelP., LasrichM., MaherJ.F.Augmentation of peritoneal transport by dopamine; comparison with norepinephrine and evaluation of pharmacologic mechanisms.J Lab Clin Med1979; 94: 747–54.
14.
HirszelP., DodgeK., MaherJ.F.Acceleration of peritoneal solute transport by cytochalasin D.Uremia Invest1985; 8: 85–9.
15.
HutchisonA.J., GokalR.Peritoneal dialysis fluids for the future: Do we have the solution?Dial Transplant1992; 21: 57–61.
16.
MactierR.A., KhannaR., MooreH., TwardowskiZ.J., NolphK.D.Pharmacologic reduction of lymphatic absorption from the peritoneal cavity increases net ultra-filtration and solute clearances in peritoneal dialysis.Nephron1988; 50: 229–32.
17.
RubinJ.Vancomycin absorption from the peritoneal cavity during dialysis -related peritonitis.Perit Dial Int1990; 10: 283–5.
18.
GrzegorzewskaA.E.Phannacologic modification of transperitoneal movement of water.Perit Dial Int1990; 10: 291–4.
19.
MaherJ.F., HirszelP., BennettR.R., ChakrabartiE.Augmentation of peritoneal hydraulic penneability byam-photericin B: Locus of action.Perit Dial Bull1984; 4: 229–31.
20.
BreborowiczA., SombolosK., RodelaH., OgilvieR., BargmanJ., OreopoulosD.Mechanism of phosphatidylcholine action during peritoneal dialysis.Perit Dial Bull1987; 7: 6–9.
21.
LamperiS., CarozziS., NasiniM.G.Calciumantagonists improve ultrafiltration in patients on continuous ambulatory peritoneal dialysis.Trans Am Soc Artiflntern Organs1987; 33: 657–63.
22.
DobbieJ.W.Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.Perit Dial Int1992; 12: 14–27.
23.
Di PaoloN., BuoncristianiU., CapotondoL.Phosphatidylcholine and peritoneal transport during peritoneal dialysis.Nephron1986; 44: 365–70.
24.
DunhamC.B., HakL.J., HullH., MattocksA.M.Enhancement of peritoneal dialysis clearance with docusate sodium.Kidney Int1981; 20: 563–8.
25.
IndrapasitS., SooksriwongseC.Effect of chlorproma zine on peritoneal clearance.Nephron1985; 40: 341–3.
